Michigan Medicine researchers are looking into a prostate cancer drug as a potential therapeutic for COVID-19. During the onset of the pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers to suspect a link between androgen receptors, which bind to hormones like testosterone-, and SARS-CoV-2 viral infection. Arul Chinnaiyan, M.D., Ph.D., notes the effects that prostate cancer drugs have on SARS-CoV-2.
